3351 Results

People

  1. Kris
    Kris
  2. Drilon
    Drilon
  3. Riely
    Riely
  4. Rudin
    Rudin
  5. Ladanyi
    Ladanyi
  6. Hellmann
    Hellmann
  7. Yu
    Yu
  8. Paik
    Paik
  9. Rusch
    Rusch
  10. Rekhtman
    Rekhtman

Groups

  1. Department of Medicine (3351)
  2. Solid Tumor Oncology Division (3351)
  3. Thoracic Oncology (3351)
  4. GSK Faculty (1056)
  5. Department of Pathology and Laboratory Medicine (797)
  6. Human Oncology and Pathogenesis Program (625)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (593)
  8. Weinberg Fellows (537)
  9. Sloan Kettering Institute Postdocs (491)
  10. Tow Center for Developmental Oncology (TCDO) (471)
  1. "Thoracic Oncology"
Formats
  1. Meeting Abstract (1694)
  2. Journal Article (1416)
  3. Review (80)
  4. Editorial (56)
  5. Book Section (35)
  6. Guidelines (24)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3351)
  2. Solid Tumor Oncology Division (3351)
  3. Thoracic Oncology (3351)
  4. GSK Faculty (1056)
  5. Department of Pathology and Laboratory Medicine (797)
  6. Human Oncology and Pathogenesis Program (625)

More Groups

People
  1. Mark Kris (869)
  2. Alexander Drilon (631)
  3. Gregory Riely (599)
  4. Charles Rudin (488)
  5. Marc Ladanyi (414)
  6. Matthew Hellmann (411)

More People

Years
  1. 2025 (73)
  2. 2024 (270)
  3. 2023 (272)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (692)
  2. Journal of Thoracic Oncology (513)
  3. Annals of Oncology (277)
  4. Clinical Cancer Research (156)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (769)
  2. Elsevier Inc. (734)
  3. American Association for Cancer Research (383)
  4. Oxford University Press (350)
  5. Nature Publishing Group (148)
  6. Elsevier Science, Inc. (78)

More Publishers

Results (3351)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A personal neoantigen vaccine, NEO-PV-01, with anti-PD1 induces broad de novo anti-tumor immunity in patients with metastatic melanoma, NSCLC, and bladder cancer
    Meeting Abstract

    Ott, P. A.; Govindan, R.; Naing, A.; Friedlander, T. W.; Margolin, K.; Lin, J. J.; Bhardwaj, N.; Hellman, M. D.; Srinivasan, L.; Greshock, J.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach
    Meeting Abstract

    Lassen, U. N.; Albert, C. M.; Kummar, S.; van Tilburg, C. M.; Dubois, S. G.; Geoerger, B.; Mascarenhas, L.; Federman, N.; Schilder, R. J.; Doz, F.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Detection and clearance of RET variants in plasma cell free DNA (cfDNA) from patients (pts) treated with LOXO-292
    Meeting Abstract

    Besse, B.; Subbiah, V.; Drilon, A.; Shah, M.; Wirth, L. J.; Bauer, T. M.; Velcheti, V.; Lakhani, N.; Boni, V.; Solomon, B. J.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Updated results of phase I study of trastuzumab deruxtecan (DS-8201a) in HER2-expressing advanced colorectal cancer
    Meeting Abstract

    Yoshino, T.; Iwata, H.; Tamura, K.; Takahashi, S.; Redfern, C.; Modi, S.; Doi, T.; Kawakami, H.; Taniguchi, H.; Takashima, A.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Phase Ib KEYNOTE-200: A study of an intravenously delivered oncolytic virus, coxsackievirus A21 in combination with pembrolizumab in advanced NSCLC and bladder cancer patients
    Meeting Abstract

    Rudin, C. M.; Pandha, H. S.; Gupta, S.; Zibelman, M. R.; Akerley, W.; Day, D.; Hill, A. G.; Sanborn, R. E.; O'Day, S. J.; Clay, T. D.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Phase I study of the AXL inhibitor DS-1205c in combination with osimertinib in subjects with metastatic or unresectable EGFR-mutant NSCLC
    Meeting Abstract

    Planchard, D.; Janne, P. A.; Yu, H. A.; Moro-Sibilot, D.; Goldberg, T.; Gu, X.; Li, J.; McGill, J.; Yu, C.; Slosberg, E.
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Translational endpoints in patients with metastatic microsatellite-stable colorectal cancer (MSS-CRC) treated with durvalumab plus monalizumab (anti-NKG2A)
    Meeting Abstract

    Diamond, J. R.; Standifer, N.; Ascierto, M. L.; Morehouse, C.; Ghadially, H.; Canales, J. R.; Rebelatto, M. C.; Naidoo, J.; Mazzarella, L.; Patel, S.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Imaging of tumor infiltrating T cells with an anti-CD8 minibody 89Zr-IAB22M2C in advanced solid tumors: A phase I first-in-human study
    Meeting Abstract

    Gordon, M. S.; Tsai, F.; Postow, M.; Hellmann, M.; Harding, J. J.; Korn, R. L.; Farwell, M. D.; Mitchell, T. C.; Schuchter, L. M.; Ziolkowska, M.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • In silico assessment of variation in TMB quantification across diagnostic platforms: Phase 1 of the Friends of Cancer Research Harmonization Project
    Meeting Abstract

    Fabrizio, D.; Chen, S. J.; Xie, M.; Chen, W.; Quin, K. J.; Zhao, C.; Zehir, A.; Funari, V.; Dickey, J. S.; Gupta, V.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Peripheral T cell dynamics in resectable NSCLC patients treated with neoadjuvant PD-1 blockade
    Meeting Abstract

    Zhang, J.; Ji, Z.; El Asmar, M.; Caushi, J.; Anagnostou, V.; Chan, H. Y.; Suri, P.; Guo, H.; Marrone, K.; Naidoo, J.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save